Blaze Bioscience, Inc.

Industry

  • Biotechnology
    • Drug Discovery Technologies
      • ADMET
  • Pharmaceuticals

Other Names/Subsidiaries

  • Blaze Bioscience Australia Pty Ltd.
See more in Biomedtracker

Latest on Blaze Bioscience, Inc.

In Vivo

Biopharma Quarterly Dealmaking Statistics, Q3 2016

 
• By Amanda Micklus and Maureen Riordan

Financings Third-quarter 2016 biopharma financing totaled $7.4 billion, a 54% increase over Q2’s $4.8 billion. Follow-on public offerings were again the lead financing vehicle, bringing in $3.36 billi

Scrip

Start-Up Quarterly Statistics, Q3 2016

 
• By Deanna Kamienski

Biopharma start-ups brought in half as much funding in the third quarter as in the second quarter, but the number of alliances for new and emerging therapeutics firms stayed the same. Big pharma made

In Vivo

Deals Shaping the Medical Industry, September 2016

 
• By Beth Allan, Steven Muntner, Maureen Riordan, and Deanna Kamienski

IN VITRO DIAGNOSTICS Mergers & Acquisitions Bio-Techne Corp. Advanced Cell Diagnostics Inc. Bio-Techne Corp. paid $250mm cash to acquire privately held molecular pathology firm Advanced Cell Dia

Scrip

Denali Builds Neurodegeneration Pipeline Through Discovery, Collaborations And Lots Of Cash

 
• By Mandy Jackson

The amount of venture capital that Denali Therapeutics Inc. has raised and the number of collaborations it's negotiated in less than two years is pretty staggering for a startup biopharmaceutical